talopeptin: from Streptomyces; similar to phosphoramidon [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 134712 |
| CHEMBL ID | 1742968 |
| SCHEMBL ID | 7155564 |
| MeSH ID | M0114195 |
| Synonym |
|---|
| n-(6-deoxy-alpha-talopyranosyloxyphospho)-leucyl-tryptophan |
| l-tryptophan, n-(n-(((6-deoxy-alpha-l-talopyranosyl)oxy)hydroxyphosphinyl)-l-leucyl)- |
| talopeptin (mki) |
| talopeptin |
| 84235-60-9 |
| (2s)-2-[[(2s)-2-[[hydroxy-[(2s,3r,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1h-indol-3-yl)propanoic acid |
| SCHEMBL7155564 |
| CHEMBL1742968 |
| (hydroxy(((2s,3r,4r,5s,6s)-3,4,5-trihydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)phosphoryl)-l-leucyl-l-tryptophan |
| Q7680303 |
| DTXSID401029277 |
| AKOS040747523 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 8 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.25) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||